Exercise may ease side effects of breast cancer treatment

NCT ID NCT07215364

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This Spanish trial tests whether a 6-month exercise program (combining resistance and aerobic training) can improve quality of life in 74 early breast cancer patients taking hormone therapy. Half the participants will do the exercise program three times a week, while the other half receive standard care. The study measures changes in symptoms and overall well-being over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
exercise program (combined resistance and aerobic training)
What this could lead to
If it works, this could show that a structured exercise program helps breast cancer patients feel better during hormone therapy.
What could go wrong
This is a small pilot study with only 74 patients, so results may not apply to everyone. The exercise program requires commitment, and some patients may not complete it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Quirón Sagrado Corazón de Sevilla

    RECRUITING

    Seville, 41013, Spain

  • Hospital Universitario 12 de Octubre

    NOT_YET_RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario Clínico San Cecilio

    RECRUITING

    Granada, 18016, Spain

  • Hospital Universitario de Navarra

    NOT_YET_RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Institut Català d'Oncología (ICO) L'Hospitalet

    NOT_YET_RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.